TransMedics (NSDQ:TMDX) today announced a public offering following positive results from a clinical trial for its organ care system. The Andover, Mass.-based organ transplant transportation technology developer revealed in a news release that it is offering $60 million in shares of common stock, plus a 30-day option to purchase additional shares that total up to 15% […]
TransMedics slides on mixed Q1
TransMedics (NSDQ:TMDX) shares took a slight dip today on first-quarter results that came up mixed compared to the consensus forecast. The Andover, Mass.-based company posted losses of -$8.9 million, or -42¢ per share, on sales of $7.5 million for the three months ended March 31, 2020, for a 28.4% bottom-line slide on sales growth of 61%. […]
TransMedics gets $2.2m loan from Paycheck Protection Program
TransMedics (NSDQ:TMDX) announced that it issued a promissory note to receive more than $2.2 million under the Paycheck Protection Program (PPP). The unsecured loan with proceeds of $2,249,280 is scheduled to mature on April 20, 2022, and includes a fixed interest rate of 1% per annum, according to an SEC filing. Under the PPP, as part […]
TransMedics down on missed Q4 projections
TransMedics (NSDQ:TMDX) shares dipped today on fourth-quarter results that came up short of the consensus forecast. The Andover, Mass.–based company posted losses of -$9.2 million, or -43¢ per share, on sales of $6.1 million for the three months ended Dec. 31, 2019, for a 20.2% bottom-line slide on sales growth of 70.9%. Adjusted to exclude one-time […]
TransMedics touts first U.S. ‘reanimated’ heart transplants
TransMedics (NSDQ:TMDX) announced today that the doctors at two hospitals performed the first U.S. heart transplants using donor hearts that were resuscitated using the company’s organ care system (OCS). The transplants from donation after circulatory death (DCD) took place at Duke University Hospital in Durham, N.C. and Massachusetts General Hospital in Boston. In a DCD procedure, […]
TransMedics shares up on Street-beating sales
TransMedics (NSDQ:TMDX) beat The Street on both sales and earnings for the third quarter and maintained its outlook for the rest of the year. In its second publicly traded quarter, Andover, Mass.-based TransMedics reported losses of -$8.28 million or -$0.39 per share on sales of $7.025 million for the three months ended Sept. 30. The […]
TransMedics touts long-distance organ transport
(NSDQ:TMDX) said today that its OCS lung transport system was used to ship donor lungs from Hawaii to the mainland U.S. for successful implantations in two patients. Donor lungs retrieved from Hawaii initially were not accepted for transplantation due to limitations of cold static storage, according to the Andover, Mass.-based company. The OCS system was […]
Transplant Biomedicals touts kidney transport device study results
Transplant Biomedicals (Barcelona, Spain) said the first-in-human clinical trial of its kidney transportation device has yielded positive results. The 32-patient study of Vivian Kidney showed an “excellent safety profile” with no device-related adverse events and no organs being discarded before implantation, the company said. The device was also associated with a low rate of delayed […]
TransMedics slides on Q1 results
Newly public TransMedics (NSDQ:TMDX) shares traded down today after the medical device maker reported first-quarter results yesterday in its debut earnings release. TransMedics developed a transportation system for organ transplants that’s designed to keep donated hearts, lungs and livers in near-living condition until transplantation. In April 2018 the company won pre-market approval from the FDA for […]
TransMedics wins expanded indication for donated lung preservation device
TransMedics (NSDQ:TMDX) said today that it won an expanded indication from the FDA for the transportation system for lung transplants it designed. In April 2018, Andover, Mass.-based TransMedics won pre-market approval from the FDA for its OCS Lung device for standard double-lung transplantation procedures; in Europe, the OCS Heart and OCS Lung devices are already on […]
TransMedics reaps $105m in IPO
TransMedics (NSDQ:TMDX) yesterday closed an initial public offering that, including a fully subscribed over-allotment, grossed nearly $105 million. Andover, Mass.-based TransMedics developed a transportation system for organ transplants that’s designed to keep donated hearts, lungs and livers in near-living condition until transplantation. A year ago it won pre-market approval from the FDA for its OCS Lung transplant device for […]
